Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Psoriasis: skin symptoms may be just the tip of the iceberg

25.10.2006
International Psoriasis Council issues a ‘call to action’ following a collaborative Consensus Meeting to review implications for clinical practice

World Psoriasis Day will have a more poignant focus this year as the International Psoriasis Council (IPC) issues a ‘call to action’ to medical experts to elevate psoriasis on the public health agenda by undertaking a more thorough therapeutic approach. Recommendations include the need to review current guidelines to ensure a more holistic approach to the management of psoriasis, taking into account the many potential co-morbidities, to prevent this significant health burden escalating. It is essential that physicians are vigilant about monitoring patients for signs of co-morbid conditions and are educated on all the therapeutic options available.

These recommendations come following a collaborative Consensus Meeting convened by the IPC held at the 15th European Academy of Dermatology and Venereology (EADV) Congress earlier this month. Multi-disciplinary medical professionals from around the globe reviewed the inflammatory nature of psoriasis and how it might be linked to co-morbid conditions such as obesity, cardiovascular disease (including hypertension, and myocardial infarction), type II diabetes and liver disease.

Dr Bruce Strober, assistant professor in the department of dermatology at New York University School of Medicine, commented, “Mounting data suggest that psoriasis is a component of an inflammatory state that nurtures significant co-morbidities. It is likely that in some patients both psoriasis and obesity are co-dependent manifestations of an underlying dysfunctional pathophysiologic state. It is important that the overall management of psoriasis is significantly improved to ensure that patients are diagnosed early, appropriately treated and regularly monitored for signs of co-morbidity.”

Among the data presented at the meeting was a statistical study of over 10,000 patients in clinical trials conducted over the past 5 years, showing that psoriasis patients are more likely to have body mass index (BMI) measurements in the overweight and obese ranges than members of the general population. Building on this point, Dr Gerald Krueger of the University of Utah presented a study which indicated that psoriasis and obesity are endpoints of a shared etiology in which one may promote the other.

Important data indicating an increased risk of cardiovascular disease was presented for the first time at the meeting. A large study by Dr Joel Gelfand of the University of Pennsylvania, recently published in the Journal of the American Medical Association, highlighted that psoriasis may be an independent risk factor for heart attack, particularly in young individuals with severe disease. Patients in their 40s with severe psoriasis were more than twice as likely to suffer a heart attack than people without the skin disease. Dr Gelfand’s findings also shed light on potential health risks for overweight psoriasis patients. These data are supported by a case-control study presented at the meeting showing that twice the number of psoriasis patients (60%) had coronary artery calcification than non-psoriasis patients (30%).

Other studies presented at the meeting indicated that patients suffer from their skin disease much more than previously understood. One trial showed that almost half of 1,000 psoriasis patients tested were likely to be clinically depressed, and another demonstrated an increased tendency to use alcohol and tobacco among psoriasis patients.

The consensus group agreed there is overwhelmingly sufficient data supporting the linkage of psoriasis to increased co-morbid risk and to mandate furture investigations funded by both government and industry. Professor Wolfram Sterry, a board member of IPC who chaired the consensus meeting concluded, “Psoriasis is a serious condition in its own right that is exacerbated by its association with co-morbidities. It is essential that physicians understand the severity of the disease and all its manifestations and integrate therapy in a way that provides a treatment that is as broad as possible to cover all the ongoing pathogenetic events.”

Asked about the outlook for the future, Dr Menter, President of IPC is optimistic: “The hope is that now that we understand better the systemic inflammatory nature of psoriasis, we can work closely with our colleagues in medicine and research to improve the general health of our psoriasis patients by using the full spectrum of medications, including the new biologic agents.”

Drs. Sterry, Menter, and Strober are currently working on a paper that will summarise the consensus of the IPC meeting, investigate the relationship between psoriasis and co-morbidities, discuss important areas for research on these issues, and issue recommendations for clinical management of psoriasis patients at risk of developing co-morbid conditions. For now it is important that everyone touched by psoriasis recognises the severity of the condition and the profound lifelong impact it has on health.

Maja Haglund | alfa
Further information:
http://www.ketchum.com
http://www.psoriasiscouncil.org

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>